With the addition of Overwatch’s end-to-end animal study management and execution system, Benchling’s R&D Cloud platform will be able to tackle the challenge of preclinical reproducibility, and help biopharma companies and contract research organisations (CROs) reduce errors, increase confidence for first-in-human studies, and ultimately get drugs to patients faster...
“Automation and industrialization of COVID-19 PCR-testing will facilitate an immense scale-up of the global PCR-testing capacity. It will allow for a new approach to keep society open: preventive, regular testing (twice per week), which will create green bubbles and get us ahead of the curve” - Niels Kruize, CCO, MolGen. To get ahead of the curve, we will need to change our methodology of COVID-19 testing...
Microbiome DX company Genetic Analysis AS (“GA”) and Institut für Medizinische Diagnostik (“IMD”), a part of the Medicover Group, announces that IMD has launched the GA-map® Dysbiosis Test in Germany. IMD will activate its new Microbiome laboratory in February 2022 and add standardized microbiota testing to its existing test portfolio of products. This new Microbiota test offering will be marketed to customers in Germany and Europe...
Biotage helps shape the sustainable science of tomorrow and our future society for the benefit of humankind – HumanKind Unlimited. With this principle Biotage has set out a commitment to unleashing the potential of humanity by working tirelessly to improve the health and wellbeing of both our customers through greener and more efficient solutions, and our own employees through smarter working practices....
OxDX, a University of Oxford spin out building instant pathogen tests using super-resolution microscopy and machine learning,has raised £2.6m in pre-seed funding for its AI powered diagnostic technology that can recognise and identify specific species and strains of viruses1,2, bacteria and other pathogens within a sample in seconds. The initial funding is co-led by IQ Capital and Ahren Innovation Capital with participation from Science Creates Ventures, and will be used to expand the team and further validate the technology with development partners...
Beckman Coulter Life Sciences continues to work with chemistry companies seeking collaborations to develop applications for the Biomek NGeniuS Next Generation Library Preparation System ahead of its launch. An application development agreement has been signed with Illumina, a developer of solutions for the sequencing and analysis of genomes, to develop new applications on the Biomek NGeniuS System...
As part of a mutual objective to safeguard high and consistent liquid handler performance levels, Hamilton Company and Artel have announced that they are near completion of a packaged solution to standardize performance validation of Hamilton’s automated liquid handlers. This packaged solution will reduce time and efforts compared to assay-specific validation methods, ensure highly consistent, accurate, and precise results, and strengthen the ability to compare performance...
Thermo Fisher Scientific, the world leader in serving science, and Symphogen, an affiliate of and the antibody center of excellence within the international pharmaceutical company Servier, announce the continuation of their collaboration to provide biopharmaceutical discovery and development laboratories with innovative tools and streamlined workflows for efficient characterization of complex therapeutic proteins...
Scitara, proven innovator in laboratory digital transformation, announces it has become a member of BioPhorum, a global community that enables collaboration throughout the biopharmaceutical industry with the goal of accelerating scientific advancements. Scitara joins BioPhorum Information Technology, whose mission is to accelerate digital maturity across the global biomanufacturing industry...
Agilent Technologies Inc. (NYSE: A) and the University of Vermont (UVM) have announced the establishment of the Agilent Laboratory for Chemical Analysis (ALCA). The facility will be a hub for advanced instrumentation that will allow students, institutional colleagues, industrial partners, and regional high-tech start-ups to study the composition and structure of chemical samples....
Dyad Medical, Inc., the developer of the cloud-based AI technology for cardiac image analysis called LibbyTM, announced that the U.S. Food and Drug Administration (FDA) has cleared LibbyTM IAAA through the 510(k) pathway. LibbyTM IAAA offers image analysis used for viewing and quantifying Intravascular Optical Coherence Tomography (IVOCT) images.
INTEGRA Biosciences has reported considerable growth for over 10 years – averaging 18 percent per annum – and more than doubling in the previous two years. The company grew by 73 percent in 2020, and has followed this with a 46 percent increase in turnover in 2021, reaching 191 million Swiss Francs. The life sciences industry is thriving, and there is currently unprecedented demand for liquid handling solutions...
The Scientific Laboratory Show and Conference is back! The event will take place on 18th of May 2022 hosted and organised by Scientific Laboratory Supplies (SLS) – the UK's largest independent supplier of chemicals, laboratory equipment and consumables. Working in partnership with the Science Council, the show is FREE to attend at the East Midlands Conference Centre in Nottingham with doors opening at 9.00am and closing at 5.00pm...
Microtrac MRB and Colloid Metrix GmbH announce that effective February 15th, 2022 Microtrac MRB has acquired the STABINO™ product line from Colloid Metrix. Microtrac MRB is a leading provider of particle characterization technologies and part of the Scientific Division of the international Verder Group. The STABINO™ has been established as a worldwide standard for the measurement of zeta potential and stability in suspensions and emulsions for many years.
Coriolis Pharma, a globally operating service provider and one of the world leaders in formulation research and development of biopharmaceuticals and vaccines, has announced the opening of its new ATMP development facilities under biosafety level S2 (BSL2 / S2). After one year of re-construction, the new facilities in close proximity to Coriolis’ headquarters in Martinsried will significantly increase Coriolis’ capabilites for ATMP development....
Nuclera, a biotech company developing cutting-edge benchtop protein printing technologies, today announced that the first close of its Series B financing has raised $42.5 million. The funds raised will be used to accelerate the development and commercialization of its eProtein™ desktop bioprinter. Nuclera’s ground-breaking protein printing technology has attracted many new and existing institutional and strategic investors...
In December 2021, ZEISS entered a strategic partnership with the Kennedy Institute of Rheumatology (KIR) and the Institute of Developmental and Regenerative Medicine (IDRM), developing the Oxford-ZEISS Centre of Excellence (Oxford-ZCoE). The Kennedy Institute of Rheumatology (KIR) is a world-leading medical research centre where discovery research drives development of transformative therapies for chronic inflammatory and degenerative disease....
A first of its kind, mobile platform for cell and gene therapy was introduced by Germfree Labs, a Florida company, at Advanced Therapies Week in Miami Beach. The new bioGO® cGMP Mobile Cleanroom solves complex logistical challenges facing the CGT (cell and gene therapy) industry. The flexible bioprocessing platform was designed by Germfree in response to critical constraints in the development, manufacturing and delivery of new and emerging curative therapies...
Insightful Science, the software company enabling the Cloud for Scientific Discovery, announce that it has acquired Omiq Inc, a company specialized in data science SaaS solutions for high dimensional flow cytometry and quantitative multi-omics data. The company’s principal product, OMIQ, is a flexible cloud platform enabling researchers to identify drug or therapeutic interactions with a biological system through the tracking of biomarkers within lab samples...
Univercells S.A. (Univercells) announces its acquisition of SynHelix, a biotechnology company that aims to debottleneck biotherapeutics development through an unprecedented robust, scalable and automated DNA synthesis technology resulting in one-step generation of long DNA fragments, in large quantities, with high purity, in a cGMP-compliant setup. SynHelix’s offering will complement the RNA platform being developed by Quantoom Biosciences...
French CRO kicks off new growth phase by boosting research capacity, with plans to use site to set up therapeutic innovation campus, including center for cryo-electron microscopy. NovAliX, a Contract Research Organization (CRO) specializing in drug research and development, today announces the first stage in its development project that will allow it to offer clients a more complete, high-quality portfolio with enhanced biological and pharmacological services...
The startup company Novel Concepts Medical is delighted to announce another major breakthrough in its research of COVID-19. Its novel plant-based treatment has resulted in successfully inhibiting the COVID-19 Omicron variant and blocking its connection to human cells. In case studies, volunteers had negative PCR results within 48 hours and quickly recovered from more than 16 symptoms of long COVID-19, including memory loss, loss of taste and smell, headaches, fatigue, and many symptoms that are common to both COVID-19 and the flu...
With the addition of Overwatch’s end-to-end animal study management and execution system, Benchling’s R&D Cloud platform will be able to tackle the challenge of preclinical reproducibility, and help biopharma companies and contract research organisations (CROs) reduce errors, increase confidence for first-in-human studies, and ultimately get drugs to patients faster...
“Automation and industrialization of COVID-19 PCR-testing will facilitate an immense scale-up of the global PCR-testing capacity. It will allow for a new approach to keep society open: preventive, regular testing (twice per week), which will create green bubbles and get us ahead of the curve” - Niels Kruize, CCO, MolGen. To get ahead of the curve, we will need to change our methodology of COVID-19 testing...
Microbiome DX company Genetic Analysis AS (“GA”) and Institut für Medizinische Diagnostik (“IMD”), a part of the Medicover Group, announces that IMD has launched the GA-map® Dysbiosis Test in Germany. IMD will activate its new Microbiome laboratory in February 2022 and add standardized microbiota testing to its existing test portfolio of products. This new Microbiota test offering will be marketed to customers in Germany and Europe...
Biotage helps shape the sustainable science of tomorrow and our future society for the benefit of humankind – HumanKind Unlimited. With this principle Biotage has set out a commitment to unleashing the potential of humanity by working tirelessly to improve the health and wellbeing of both our customers through greener and more efficient solutions, and our own employees through smarter working practices....
OxDX, a University of Oxford spin out building instant pathogen tests using super-resolution microscopy and machine learning,has raised £2.6m in pre-seed funding for its AI powered diagnostic technology that can recognise and identify specific species and strains of viruses1,2, bacteria and other pathogens within a sample in seconds. The initial funding is co-led by IQ Capital and Ahren Innovation Capital with participation from Science Creates Ventures, and will be used to expand the team and further validate the technology with development partners...
Beckman Coulter Life Sciences continues to work with chemistry companies seeking collaborations to develop applications for the Biomek NGeniuS Next Generation Library Preparation System ahead of its launch. An application development agreement has been signed with Illumina, a developer of solutions for the sequencing and analysis of genomes, to develop new applications on the Biomek NGeniuS System...
As part of a mutual objective to safeguard high and consistent liquid handler performance levels, Hamilton Company and Artel have announced that they are near completion of a packaged solution to standardize performance validation of Hamilton’s automated liquid handlers. This packaged solution will reduce time and efforts compared to assay-specific validation methods, ensure highly consistent, accurate, and precise results, and strengthen the ability to compare performance...
Thermo Fisher Scientific, the world leader in serving science, and Symphogen, an affiliate of and the antibody center of excellence within the international pharmaceutical company Servier, announce the continuation of their collaboration to provide biopharmaceutical discovery and development laboratories with innovative tools and streamlined workflows for efficient characterization of complex therapeutic proteins...
Scitara, proven innovator in laboratory digital transformation, announces it has become a member of BioPhorum, a global community that enables collaboration throughout the biopharmaceutical industry with the goal of accelerating scientific advancements. Scitara joins BioPhorum Information Technology, whose mission is to accelerate digital maturity across the global biomanufacturing industry...
Agilent Technologies Inc. (NYSE: A) and the University of Vermont (UVM) have announced the establishment of the Agilent Laboratory for Chemical Analysis (ALCA). The facility will be a hub for advanced instrumentation that will allow students, institutional colleagues, industrial partners, and regional high-tech start-ups to study the composition and structure of chemical samples....
Dyad Medical, Inc., the developer of the cloud-based AI technology for cardiac image analysis called LibbyTM, announced that the U.S. Food and Drug Administration (FDA) has cleared LibbyTM IAAA through the 510(k) pathway. LibbyTM IAAA offers image analysis used for viewing and quantifying Intravascular Optical Coherence Tomography (IVOCT) images.
INTEGRA Biosciences has reported considerable growth for over 10 years – averaging 18 percent per annum – and more than doubling in the previous two years. The company grew by 73 percent in 2020, and has followed this with a 46 percent increase in turnover in 2021, reaching 191 million Swiss Francs. The life sciences industry is thriving, and there is currently unprecedented demand for liquid handling solutions...
The Scientific Laboratory Show and Conference is back! The event will take place on 18th of May 2022 hosted and organised by Scientific Laboratory Supplies (SLS) – the UK's largest independent supplier of chemicals, laboratory equipment and consumables. Working in partnership with the Science Council, the show is FREE to attend at the East Midlands Conference Centre in Nottingham with doors opening at 9.00am and closing at 5.00pm...
Microtrac MRB and Colloid Metrix GmbH announce that effective February 15th, 2022 Microtrac MRB has acquired the STABINO™ product line from Colloid Metrix. Microtrac MRB is a leading provider of particle characterization technologies and part of the Scientific Division of the international Verder Group. The STABINO™ has been established as a worldwide standard for the measurement of zeta potential and stability in suspensions and emulsions for many years.
Coriolis Pharma, a globally operating service provider and one of the world leaders in formulation research and development of biopharmaceuticals and vaccines, has announced the opening of its new ATMP development facilities under biosafety level S2 (BSL2 / S2). After one year of re-construction, the new facilities in close proximity to Coriolis’ headquarters in Martinsried will significantly increase Coriolis’ capabilites for ATMP development....
Nuclera, a biotech company developing cutting-edge benchtop protein printing technologies, today announced that the first close of its Series B financing has raised $42.5 million. The funds raised will be used to accelerate the development and commercialization of its eProtein™ desktop bioprinter. Nuclera’s ground-breaking protein printing technology has attracted many new and existing institutional and strategic investors...
In December 2021, ZEISS entered a strategic partnership with the Kennedy Institute of Rheumatology (KIR) and the Institute of Developmental and Regenerative Medicine (IDRM), developing the Oxford-ZEISS Centre of Excellence (Oxford-ZCoE). The Kennedy Institute of Rheumatology (KIR) is a world-leading medical research centre where discovery research drives development of transformative therapies for chronic inflammatory and degenerative disease....
A first of its kind, mobile platform for cell and gene therapy was introduced by Germfree Labs, a Florida company, at Advanced Therapies Week in Miami Beach. The new bioGO® cGMP Mobile Cleanroom solves complex logistical challenges facing the CGT (cell and gene therapy) industry. The flexible bioprocessing platform was designed by Germfree in response to critical constraints in the development, manufacturing and delivery of new and emerging curative therapies...
Insightful Science, the software company enabling the Cloud for Scientific Discovery, announce that it has acquired Omiq Inc, a company specialized in data science SaaS solutions for high dimensional flow cytometry and quantitative multi-omics data. The company’s principal product, OMIQ, is a flexible cloud platform enabling researchers to identify drug or therapeutic interactions with a biological system through the tracking of biomarkers within lab samples...
Univercells S.A. (Univercells) announces its acquisition of SynHelix, a biotechnology company that aims to debottleneck biotherapeutics development through an unprecedented robust, scalable and automated DNA synthesis technology resulting in one-step generation of long DNA fragments, in large quantities, with high purity, in a cGMP-compliant setup. SynHelix’s offering will complement the RNA platform being developed by Quantoom Biosciences...
French CRO kicks off new growth phase by boosting research capacity, with plans to use site to set up therapeutic innovation campus, including center for cryo-electron microscopy. NovAliX, a Contract Research Organization (CRO) specializing in drug research and development, today announces the first stage in its development project that will allow it to offer clients a more complete, high-quality portfolio with enhanced biological and pharmacological services...
The startup company Novel Concepts Medical is delighted to announce another major breakthrough in its research of COVID-19. Its novel plant-based treatment has resulted in successfully inhibiting the COVID-19 Omicron variant and blocking its connection to human cells. In case studies, volunteers had negative PCR results within 48 hours and quickly recovered from more than 16 symptoms of long COVID-19, including memory loss, loss of taste and smell, headaches, fatigue, and many symptoms that are common to both COVID-19 and the flu...